Form 4: Amedisys Director Bruce D. Perkins Acquires Restricted Stock Units

Director Bruce D. Perkins acquired 1,678 restricted stock units in Amedisys Inc. on May 3, 2024.

Summary

• On May 3, 2024, Bruce D. Perkins, a director of Amedisys Inc., acquired 1,678 restricted stock units (RSUs).
• These RSUs represent a contingent right to receive one share of Amedisys' common stock each.
• The RSUs will vest 100% on May 3, 2025, contingent upon Perkins' continued service as a non-employee member of the Issuer's Board of Directors.
• Following the transaction, Perkins beneficially owns 22,407 shares of Amedisys Inc. common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of RSUs is a common practice and signals confidence in the company's future.

Positives

• The acquisition of restricted stock units aligns the director's interests with the long-term performance of the company.
• The vesting condition encourages continued service and commitment to Amedisys Inc.

Future Outlook

The restricted stock units will vest on May 3, 2025, contingent upon the director's continued service.

Industry Context

This is a standard practice for aligning the interests of company directors with those of shareholders, common in the healthcare services industry.

Comparison to Industry Standards

• Granting restricted stock units to board members is a common practice among publicly traded companies, including those in the healthcare sector like UnitedHealth Group (UNH) and Humana (HUM).
• The vesting schedules and amounts granted are typically benchmarked against peer companies to ensure competitive compensation packages.

Stakeholder Impact

• The granting of restricted stock units aligns the director's interests with those of the shareholders.
• This can potentially lead to better decision-making and increased shareholder value.

Key Dates